DK1145002T4 - Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptor - Google Patents
Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptorInfo
- Publication number
- DK1145002T4 DK1145002T4 DK99930956T DK99930956T DK1145002T4 DK 1145002 T4 DK1145002 T4 DK 1145002T4 DK 99930956 T DK99930956 T DK 99930956T DK 99930956 T DK99930956 T DK 99930956T DK 1145002 T4 DK1145002 T4 DK 1145002T4
- Authority
- DK
- Denmark
- Prior art keywords
- calcium
- coupled receptor
- agonists
- antagonists
- bioluminescence test
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98870149 | 1998-07-06 | ||
PCT/BE1999/000087 WO2000002045A2 (fr) | 1998-07-06 | 1999-07-06 | Diagnostic a haut rendement et/ou procede de dosage d'un agoniste et/ou antagoniste d'un recepteur a couplage calcium |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1145002T3 DK1145002T3 (da) | 2003-05-05 |
DK1145002T4 true DK1145002T4 (da) | 2009-03-16 |
Family
ID=8237065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99930956T DK1145002T4 (da) | 1998-07-06 | 1999-07-06 | Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptor |
Country Status (9)
Country | Link |
---|---|
US (1) | US6872538B1 (fr) |
EP (1) | EP1145002B2 (fr) |
JP (1) | JP3495987B2 (fr) |
AT (1) | ATE232298T1 (fr) |
CA (1) | CA2336929C (fr) |
DE (1) | DE69905291T3 (fr) |
DK (1) | DK1145002T4 (fr) |
ES (1) | ES2192060T5 (fr) |
WO (1) | WO2000002045A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
US6248542B1 (en) | 1997-12-09 | 2001-06-19 | Massachusetts Institute Of Technology | Optoelectronic sensor |
DE10008373C2 (de) * | 2000-02-23 | 2002-11-28 | Helmut Adelsberger | Verfahren und Vorrichtung zur Bestimmung der Ionenkanalaktivität |
CN100507003C (zh) | 2001-02-07 | 2009-07-01 | 麻省理工学院 | 光电子探测系统 |
US8216797B2 (en) | 2001-02-07 | 2012-07-10 | Massachusetts Institute Of Technology | Pathogen detection biosensor |
US7422860B2 (en) | 2001-02-07 | 2008-09-09 | Massachusetts Institute Of Technology | Optoelectronic detection system |
WO2002075273A2 (fr) * | 2001-03-20 | 2002-09-26 | Euroscreen S.A. | Dispositif et procede de triage, de diagnostic et/ou de dosage d'un agoniste et/ou antagoniste d'un recepteur couple au calcium |
GB0108143D0 (en) * | 2001-03-31 | 2001-05-23 | Univ Dundee | High-throughput screen |
WO2003057730A1 (fr) | 2002-01-07 | 2003-07-17 | Euroscreen S.A. | Ligand du recepteur gpr43 couple a une proteine g et utilisations de ce ligand |
JP2006519763A (ja) | 2002-11-08 | 2006-08-31 | アブリンクス エン.ヴェー. | 治療用ポリペプチドの投与法およびそのためのポリペプチド |
GB0228139D0 (en) * | 2002-12-03 | 2003-01-08 | Kozlova Zwinderman Olga | Fungal biosensor for contaminant detection |
NZ540771A (en) | 2003-01-10 | 2009-05-31 | Ablynx Nv | Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen |
ATE485307T1 (de) | 2003-11-07 | 2010-11-15 | Ablynx Nv | Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung |
ITMI20040598A1 (it) * | 2004-03-26 | 2004-06-26 | Carlotta Giorgi | Metodo per la rilevazione di parametri intracellulari con sonde proteiche luminescenti per lo screening di molecole in grado di alterare detti parametri |
CA2810292C (fr) | 2004-05-14 | 2015-09-29 | Euroscreen S.A. | Ligand pour recepteur fprl2 couple aux proteines g et leur utilisation |
EP1888640B1 (fr) | 2005-05-18 | 2012-03-14 | Ablynx N.V. | Nanocorps ameliores utilises contre le facteur-alpha de necrose tumorale |
MX2007014564A (es) | 2005-05-20 | 2008-02-07 | Ablynx Nv | Anticuerpos de vhh de dominio unico contra el factor de von willebrand. |
WO2007100618A2 (fr) * | 2006-02-23 | 2007-09-07 | Atto Bioscience | Nouveaux dosages cellulaires de la phosphodiestérase |
US20080287371A1 (en) * | 2007-05-17 | 2008-11-20 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex |
JP2012533298A (ja) | 2009-07-14 | 2012-12-27 | イー・エム・デイー・ミリポア・コーポレイシヨン | カルシウム親和性の増加と生物発光の増強を示す改変型発光蛋白質及びその使用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5422266A (en) | 1984-12-31 | 1995-06-06 | University Of Georgia Research Foundation, Inc. | Recombinant DNA vectors capable of expressing apoaequorin |
JPH01285196A (ja) | 1988-05-11 | 1989-11-16 | Chisso Corp | 発光蛋白エクオリンの製造法 |
JPH02253162A (ja) † | 1989-03-27 | 1990-10-11 | Chisso Corp | 特異的結合能を有する物質と結合したエクオリンを用いる検出法 |
EP0372352B1 (fr) † | 1988-12-06 | 1995-06-07 | Chisso Corporation | Aéquorine fusionnée avec une protéine ayant une activité de liaison spécifique, sa préparation, sa purification et méthode de détection l'utilisant |
JPH03153700A (ja) † | 1989-11-09 | 1991-07-01 | Chisso Corp | 物理吸着法により担体に固定化されたエクオリン活性を示す蛋白質 |
US5714666A (en) † | 1993-02-09 | 1998-02-03 | Children's Hospital Of Philadelphia | Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells |
US5744320A (en) † | 1995-06-07 | 1998-04-28 | Promega Corporation | Quenching reagents and assays for enzyme-mediated luminescence |
-
1999
- 1999-07-06 US US09/743,405 patent/US6872538B1/en not_active Expired - Lifetime
- 1999-07-06 DE DE69905291T patent/DE69905291T3/de not_active Expired - Lifetime
- 1999-07-06 DK DK99930956T patent/DK1145002T4/da active
- 1999-07-06 EP EP99930956A patent/EP1145002B2/fr not_active Expired - Lifetime
- 1999-07-06 JP JP2000558390A patent/JP3495987B2/ja not_active Expired - Lifetime
- 1999-07-06 CA CA002336929A patent/CA2336929C/fr not_active Expired - Lifetime
- 1999-07-06 AT AT99930956T patent/ATE232298T1/de active
- 1999-07-06 ES ES99930956T patent/ES2192060T5/es not_active Expired - Lifetime
- 1999-07-06 WO PCT/BE1999/000087 patent/WO2000002045A2/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2192060T3 (es) | 2003-09-16 |
DE69905291T3 (de) | 2009-06-25 |
EP1145002B2 (fr) | 2008-12-10 |
WO2000002045A3 (fr) | 2001-11-08 |
CA2336929C (fr) | 2005-10-04 |
ES2192060T5 (es) | 2009-05-01 |
JP3495987B2 (ja) | 2004-02-09 |
DK1145002T3 (da) | 2003-05-05 |
CA2336929A1 (fr) | 2000-01-13 |
EP1145002B1 (fr) | 2003-02-05 |
WO2000002045A2 (fr) | 2000-01-13 |
JP2002519699A (ja) | 2002-07-02 |
DE69905291T2 (de) | 2003-11-06 |
EP1145002A2 (fr) | 2001-10-17 |
US6872538B1 (en) | 2005-03-29 |
DE69905291D1 (de) | 2003-03-13 |
ATE232298T1 (de) | 2003-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1145002T4 (da) | Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptor | |
ATE218708T1 (de) | Elektrochemischer affinitätsassay | |
DE69029812T2 (de) | Elemente für retinsäureantwortzusammensetzung und nachweisverfahren | |
BR9914933A (pt) | Gerenciamento do modo inativo em uma rede hìbrida gsm / cdma | |
ES2129658T3 (es) | Identificacion de ligandos mediante amplificacion selectiva de celulas transfectadas con receptores. | |
DE69011329D1 (de) | Pdgf-alpha-rezeptor. | |
DE69133135D1 (de) | Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes | |
BR9915055A (pt) | Teste diagnóstico de tuberculose | |
ES2114548T3 (es) | Procedimiento y composiciones para ensayos de complementacion de enzima utilizando la region omega de beta-galactosidasa. | |
AR010041A1 (es) | Agonistas multifuncionales quimericos de receptores de hematopoyetina | |
BR0011741A (pt) | Compostos de organossilila tendo atividade de modulação do receptor de hormÈnio nuclear | |
Schindler et al. | Localization of the somatostatin sst2 (a) receptor in human cerebral cortex, hippocampus and cerebellum | |
DE69428292D1 (de) | Rekombinanter c140-rezeptor, seine agonisten und antagonisten | |
CA2091637A1 (fr) | Surveillance d'appels en cours | |
WO2004037160A3 (fr) | Test in vitro permettant d'etudier un compose prevoyant les parametres pharmacologiques et/ou pharmacocinetiques et/ou pharmacodynamiques d'un compose | |
NZ524693A (en) | Methods for identifying VPAC receptor agonists for treating muscle atrophy using vasoactive intestinal peptide receptors | |
DK1185873T3 (da) | Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet | |
WO2002075273A3 (fr) | Dispositif et procede de triage, de diagnostic et/ou de dosage d'un agoniste et/ou antagoniste d'un recepteur couple au calcium | |
DK1095275T3 (da) | Endogen, konstitutivt aktiverede G-protein-koblede orphan-receptorer | |
Yeon et al. | Molecular mechanisms underlying calcium current modulation by nociceptin | |
BR9912489A (pt) | Processo para controlar acesso a serviços sem fios por uma estação móvel, e, estação móvel para uso em uma rede sem fios que provê serviços de comunicação em ambos canais de controle analógicos e canais de controle digitais | |
AU2001257211A1 (en) | Peptide potentiation of acid-sensory ion channel in pain | |
EP0892046A3 (fr) | Cellules exprimant le récepteur de melatonine et leurs applications | |
MY130846A (en) | Method for providing liquid and solid components of a sample for use in assay methods | |
PL316311A1 (en) | Agents for treating autoimmunisation diseases and method of treating such diseases |